Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

Next Previous
Trial Profile

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Therapeutic Use
  • Acronyms GIHP-NACO registry

    • Most Recent Events

    • 01 Aug 2022 Results (n=478) of an analysis assessing management strategies and outcomes of urgent, non-haemostatic invasive procedures in patients treated with DOACs published in the Thrombosis Research
    • 28 Jul 2015 Planned number of patients changed from 300 to 842, as reported by ClinicalTrials.gov.
    • 28 Jul 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top